Direct reporting of side effects by the patient: Favourable experience in the first year;Meldingen van bijwerkingen rechtstreeks door patiënten: Gunstige ervaringen van het eerste jaar

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 10, 2005, Pages 529-533

  Van Grootheest, A C ^a   Passier, J L M ^a   Van Puijenbroek, E P ^a  

^a Nederlands Bijwerkingen Centrum Lareb   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

ADVERSE DRUG REACTION; ARTICLE; DISEASE SEVERITY; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; HUMAN; NETHERLANDS; PATIENT; PHARMACIST; PHYSICIAN; SELF REPORT; SIDE EFFECT;

DATABASES, FACTUAL; DRUG INFORMATION SERVICES; HUMANS; NETHERLANDS; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 14844343673     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lindquist AM. Seeing and observing in international pharmacovigilance [proefschrift]. Nijmegen: Katholieke Universiteit Nijmegen; 2003.
2. World Health Organization (WHO). International drug monitoring: the role of national centres. Technical report series. Genève: WHO; 1972.
3. Grootheest AC van, Puijenbroek EP van, Jong-van den Berg LT de. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf 2002;11:205-10.
4. Morrison-Griffiths S, Walley TJ, Park BK, Breckenndge AM, Pirmohammed M. Reporting of adverse drug reactions by nurses. Lancet 2003;361:1347-8.
5. Grootheest K van, Jong-van den Berg LT de. Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf 2004;3:363-8.
6. Kennedy DL, Goldman SA, Lillie RB. Spontaneous reporting in the United States. In: Strom WHW, editor. Pharmacoepidemiology. Chichester: Wiley; 2000. p. 151-74.
7. Grootheest AC van, Graaf L de, Jong-van den Berg LT de. Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Saf 2003;26:211-7.
8. Medawar C, Herxheimer A, Bell A, Jofre S. Paroxetine, Panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int J Risk Saf Med 2002;15:161-9.
9. Solovitz BL, Fisher S, Bryand SG, Kluge RM. How well can patients discriminate drug-related side effects from extraneous new symptoms? Psychopharmocol Bull 1987;23:189-92.
10. Eland IA, Belton KJ, Grootheest AC van, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999;48:623-7.
11. Egberts TL, Smulders M, Koning FH de, Meyboom RH, Leufkens HG. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ 1996;313:530-1.
12. Egberts AC, Koning FH de, Meyboom RH, Leufkens HG. ADR-related questions received by a telephone medicine information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs. Pharmacoepidemiol Drug Saf 1997; 6:269-76.